NASDAQ:DMRA | Profit Breakdown | Damora Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$34.99M-$30.92M-$31.17M
2026-03-31-$30.81M-$27.74M-$27.78M
2025-12-31-$201.7M-$200.69M-$200.74M
2025-09-30-$3.16M-$3.13M-$3.13M
2025-06-30-$3.42M-$3.43M-$3.44M
2025-03-31-$2.6M-$2.53M-$2.53M
2024-12-31-$7.1M-$6.75M-$6.74M
2024-09-30-$3.84M-$3.88M-$3.88M
2024-06-30-$5.58M-$5.3M-$5.34M
2024-03-31-$5.74M-$5.48M-$5.48M
2023-12-31-$6.67M-$6.48M-$6.48M
2023-09-30-$8.58M-$8.14M-$8.14M
2023-06-30-$11.16M-$10.74M-$10.74M
2023-03-31-$13.49M-$12.99M
2022-12-31-$13.53M-$14.07M
2022-09-30-$13.62M-$13.73M
2022-06-30-$17.12M-$16.89M
2022-03-31-$16.94M-$16.94M
2021-12-31-$13.47M-$13.41M
2021-09-30-$12.94M-$12.7M
2021-06-30-$12.27M-$12.3M
2021-03-31-$13.55M-$13.35M
2020-12-31-$11.3M-$11.58M
2020-09-30-$10.17M-$11.65M
2020-06-30-$6.34M-$5.94M
2020-03-31-$5.83M-$5.67M
2019-12-31$24.85M-$24.42M
2019-09-30$4.83M-$4.11M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$210.87M-$209.79M-$209.84M
2024-12-31-$22.26M-$21.4M-$21.44M
2023-12-31-$39.91M-$38.35M-$38.35M
2022-12-31-$61.21M-$61.62M-$61.62M
2021-12-31-$52.23M-$51.75M-$51.75M
2020-12-31-$33.64M-$34.84M-$34.84M
2019-12-31$38.97M-$36.51M-$36.51M